Acarbose is an effective treatment for severe hypertriglyceridemia secondary to l-asparaginase and dexamethasone

Leukemia and Lymphoma

Volumn 53, Issue 6, 2012, Pages 1245-1246

  Tan, Matthew ^a   Wai, Daniel ^a   Chng, Chiaw Ling ^a   Hwang, William ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; LIPOPROTEIN LIPASE; METHOTREXATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; CASE REPORT; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; PRIORITY JOURNAL;

ACARBOSE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; DEXAMETHASONE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIC AGENTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84861354338     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.647312     Document Type: Letter

References (13)

1. Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997;89:1886-1895. (Pubitemid 27132102)
2. Cohen H, Bielorai B, Harats D, et al. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010;54:703-706.
3. Hoogerbrugge N, Jansen H, Hoogerbrugge PM. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase acitivity. Leukemia 1997;11:1377-1379. (Pubitemid 27387319)
4. Tozuka M, Yamauchi K, Hidaka H, et al. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma. Ann Clin Lab Sci 1997;27:351-357. (Pubitemid 27386469)
5. Cremer P, Lakomek M, Beck W, et al. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukemia. Eur J Pediatr 1988;147:64-67. (Pubitemid 18027564)
6. T askinen MR, Nikkila EA, Pelkonen R, et al. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1983;57:619-626. (Pubitemid 13005532)
7. Staels B, van Tol A, Chan L, et al. Variable effects of diff erent corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Th romb 1991; 11:760-769.
8. Ridola V, Buonuoma PS, Maurizi P, et al. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer 2008;50:378-380.
9. Kfoury-Baz EM, Nassar RA, Tanios RF, et al. Plasmapheresis in asparaginase-induced hypertriglyceridemia. Transfusion 2008;48: 1227-1230. (Pubitemid 351793486)
10. Nakagawa M, Kimura S, Fujimoto K, et al. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis. Ther Apher Dial 2008;12:509-513.
11. Kado S, Murakami T, Aoki A, et al. Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus. Diabetes Res Clin Pract 1998;41:49-55. (Pubitemid 28394284)
12. Ogawa S, Takeuchi K, Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab 2004;6:384-390. (Pubitemid 39177431)
13. Malaguarnera M, Giugno I, Ruello P, et al. Acarbose is an Effective adjunct to dietary therapy in the treatment of hypertriglyceidaemias. Br J Clin Pharmacol 1999;48:605-609. (Pubitemid 29454242)